Literature DB >> 10678286

Localization and function of angiotensin AT1 receptors.

A M Allen1, J Zhuo, F A Mendelsohn.   

Abstract

The distributions of angiotensin AT1 and AT2 receptors have been mapped by in vitro autoradiography throughout most tissues of many mammals, including humans. In addition to confirming that AT1 receptors occur in sites known to be targets for the physiologic actions of angiotensin, such as the adrenal cortex and medulla, renal glomeruli and proximal tubules, vascular and cardiac muscle and brain circumventricular organs, many new sites of action have been demonstrated. In the kidney, AT1 receptors occur in high density in renal medullary interstitial cells. The function of these cells, which span the interstitial space between the tubules and the vasa rectae, remains to be determined. Renal medullary interstitial cells possess receptors for a number of vasoactive hormones in addition to AT1 receptors and this, in concert with their anatomic location, suggests they may be important for the regulation of fluid reabsorption or renal medullary blood flow. In the heart, the highest densities of AT1 receptors occur in association with the conduction system and vagal ganglia. In the central nervous system, high AT1 receptor densities occur in many regions behind the blood-brain barrier, supporting a role for neurally derived angiotensin as a neuromodulator. The physiologic role of angiotensin in many of these brain sites remains to be determined. The AT2 receptor also has a characteristic distribution in several tissues including the adrenal gland, heart, and brain. The role of this receptor in physiology is being elucidated, but it appears to inhibit proliferation and to participate in development. Thus, receptor-binding studies, localizing the distribution of AT1 and AT2 receptors, provide many insights into novel physiologic roles of angiotensin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10678286     DOI: 10.1016/s0895-7061(99)00249-6

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  62 in total

1.  Angiotensin II stimulates H⁺-ATPase activity in intercalated cells from isolated mouse connecting tubules and cortical collecting ducts.

Authors:  Carsten A Wagner; Nilufar Mohebbi; Ulrike Uhlig; Gerhard H Giebisch; Sylvie Breton; Dennis Brown; John P Geibel
Journal:  Cell Physiol Biochem       Date:  2011-11-18

2.  Expression of astrocytic type 2 angiotensin receptor in central nervous system inflammation correlates with blood-brain barrier breakdown.

Authors:  Laila Füchtbauer; Henrik Toft-Hansen; Reza Khorooshi; Trevor Owens
Journal:  J Mol Neurosci       Date:  2010-04-23       Impact factor: 3.444

3.  ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension.

Authors:  Srinivas Sriramula; Jeffrey P Cardinale; Eric Lazartigues; Joseph Francis
Journal:  Cardiovasc Res       Date:  2011-09-27       Impact factor: 10.787

4.  Central losartan attenuates increases in arterial pressure and expression of FosB/ΔFosB along the autonomic axis associated with chronic intermittent hypoxia.

Authors:  W David Knight; Ashwini Saxena; Brent Shell; T Prashant Nedungadi; Steven W Mifflin; J Thomas Cunningham
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-09-11       Impact factor: 3.619

5.  Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system.

Authors:  Marc F Doobay; Lauren S Talman; Teresa D Obr; Xin Tian; Robin L Davisson; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-08-31       Impact factor: 3.619

6.  HDAC inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats.

Authors:  Jeffrey P Cardinale; Srinivas Sriramula; Romain Pariaut; Anuradha Guggilam; Nithya Mariappan; Carrie M Elks; Joseph Francis
Journal:  Hypertension       Date:  2010-08-02       Impact factor: 10.190

7.  A mouse model of heart failure with preserved ejection fraction due to chronic infusion of a low subpressor dose of angiotensin II.

Authors:  Jessica A Regan; Adolfo Gabriele Mauro; Salvatore Carbone; Carlo Marchetti; Rabia Gill; Eleonora Mezzaroma; Juan Valle Raleigh; Fadi N Salloum; Benjamin W Van Tassell; Antonio Abbate; Stefano Toldo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-17       Impact factor: 4.733

Review 8.  Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review.

Authors:  Bart Stragier; Dimitri De Bundel; Sophie Sarre; Ilse Smolders; Georges Vauquelin; Alain Dupont; Yvette Michotte; Patrick Vanderheyden
Journal:  Heart Fail Rev       Date:  2007-11-08       Impact factor: 4.214

9.  Androgen Receptor Blockade Differentially Regulates Blood Pressure in Growth-Restricted Versus Ovarian Deficient Rats.

Authors:  Gwendolyn K Davis; Suttira Intapad; Ashley D Newsome; Laura E Coats; Daniel R Bamrick; Norma B Ojeda; Barbara T Alexander
Journal:  Hypertension       Date:  2019-08-05       Impact factor: 10.190

10.  Central administration of TRV027 improves baroreflex sensitivity and vascular reactivity in spontaneously hypertensive rats.

Authors:  Alynne Carvalho-Galvão; Blessing Ogunlade; Jiaxi Xu; Cristiane R A Silva-Alves; Leônidas G Mendes-Júnior; Drielle D Guimarães; Josiane C Cruz; Thyago M Queiroz; Camille M Balarini; Valdir A Braga; Catalin M Filipeanu; Eric Lazartigues; Maria do Socorro de França-Silva
Journal:  Clin Sci (Lond)       Date:  2018-07-23       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.